Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Xyon Health Inc. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This activity is handled by 1 distinct examiner and 1 distinct art unit, showing a narrow focus for the company's current patent prosecution. The centralized nature of this workload means that the company's immediate patenting goals are tied to a single examination path. This structure allows for a more streamlined communication process between the applicant and the 1 distinct examiner.
The busiest examiner for this portfolio is JUSTICE, GINA CHIEUN YU, who is responsible for 1 pending office action. This examiner manages the only pending action for Xyon Health Inc. as indicated in the data. Because there is 1 distinct art unit involved, the technical scope remains within a specific domain of biotechnology. This allows the practitioner to focus on the specific examination patterns and preferences of JUSTICE, GINA CHIEUN YU to advance the application. Tailoring the technical arguments to meet the specific requirements of this examiner is critical for resolving the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JUSTICE, GINA CHIEUN YU | 1 | 55.6% | +8.5% |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17922748 | TOPICAL FORMULATIONS COMPRISING DUTASTERIDE FOR TREATING DERMATOLOGICAL DISORDERS INCLUDING MALE PATTERN BALDNESS | JUSTICE, GINA CHIEUN YU | 1617 | §103DP | Non-Final OA | — | Pending | Nov 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialXyon Health Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Gina Chieun Yu Justice has the most, with 1 of Xyon Health Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
